Veru Announces Publication Of Data From Three Cancer Studies As Part Of The Upcoming American Society Of Clinical Oncology Annual Meeting | Latest News RSS feed

Veru Announces Publication Of Data From Three Cancer Studies As Part Of The Upcoming American Society Of Clinical Oncology Annual Meeting - Latest News


Veru Announces Publication of Data from Three Cancer Studies as Part of the Upcoming American Society of Clinical Oncology Annual Meeting

--Data of Company’s Proprietary Drug, Oral VERU-111, Shows Efficacy in Multiple Cancer Models: Human Taxane-Resistant Triple Negative Breast Cancer, Pancreatic Cancer and Ovarian Cancer-- MIAMI, May 1... read more

Selecta Biosciences Announces Second Quarter 2018 Financial Results and Provides Corporate Update

“The continued improvement in clinical ... cancer, and is further exploring additional studies in other cancers. Preclinical Work Continues in Gene Therapy: Previously presented data from the 2017 ann... read more

Curis, Inc. (CRIS)

On November 7, 2017, Curis, Inc. announced its financial results for the three ... Cancer (SITC) Meeting. In our CUDC-907 program, we expect to present data supporting its clinical benefit in patients ... read more

Looking for another news?


MP announces intent to grill Minister of Commerce

it concerns a matter of national security. The ruling on Wednesday at 0800 GMT – in the grand surroundings of the 1913-built Peace Palace in the Dutch city – follows four days of hearings at the end o... read more


AbbVie's Upadacitinib (ABT-494) Meets Primary Endpoint in Phase 2b Study in Atopic Dermatitis

Additional data will be presented at an upcoming ... Clinical trial results and radiation oncology research to be featured at ASTRO's Annual Meeting in San Antonio The American Society for Radiation O... read more

Curis Reports Third Quarter 2017 Financial Results

In our CUDC-907 program, we expect to present data supporting its clinical benefit in patients with MYC-altered DLBCL at the upcoming American Society ... Cancer (SITC) 32 nd Annual Meeting (Nov. 8-12 ... read more

Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates

Three notable publications provided particularly meaningful clinical insight into single-agent ibrutinib. In addition to the aforementioned publication by Levy ... at the AACR Meeting featured a data ... read more

Health: Other - KXXV Central Texas News Now

“Rhinitis”, the medical term for inflammation of the nose, gets no respect. Rhinitis is a common disorder that affects quality of life and has medical consequences if left untreated. Many medical...Mo... read more

InPlay from Briefing.com

8:32 am Cidara Therapeutics announces publication of data ... Upcoming Milestones September 11-15, 2017 -- Two oral presentations (inTandem2 and JDRF studies) and two poster presentations (dose rangin... read more

Curis : Reports Third Quarter 2017 Financial Results

Precision oncology (CA-4948, IRAK4 inhibitor program): Curis announces U.S. FDA acceptance of the IND to ... MYC-altered DLBCL program): In August 2017, Curis reported data from the interim analysis o... read more

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

Menarini Ricerche will present tomorrow, September 20th, at the 60th Annual Meeting of the Italian Cancer Society (SIC), new preclinical data showing ... announced today the publication of biomarker r... read more

Curis Reports First Quarter 2017 Financial Results

McNab Jr. will retire from the Company’s Board of Directors effective as of the date of the Company’s annual shareholder meeting on May 16 ... demonstrate sufficient safety and efficacy in clinical st... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us